This corona vaccine is important for India !, Learn its features and price

  This corona vaccine is important for India !, Learn its features and price

The corona vaccine is awaited and soon this long wait is about to end. Corolla vaccination is in the final stages in many countries. The good news is that many of these vaccines are proving to be more than 90 percent effective in the treatment of corona.

The corona vaccine is awaited and soon this long wait is about to end. Corolla vaccination is in the final stages in many countries. The good news is that many of these vaccines are proving to be more than 90 percent effective in the treatment of corona.

In this case, the University of Oxford vaccine is proving to be the most effective. Because the results are good. Second, its cost and subsequent storage at low temperatures make it different from other vaccines.

AZD1222 and Covishield

Oxford University and AstraZeneca have jointly developed a corona vaccine. The vaccine is being developed under the name AZD1222. While in India this vaccine is being manufactured under the name of Covishield.

Good Covid-19 vaccine Trail

The results of the third phase trial of this vaccine have been announced. The results showed that the effect of the vaccine was 70.4 percent if we look at the mass statistics of double dose. In two different doses its effect was found to be 90 per cent once and 62 per cent the second time.

Trial done in two ways

The Oxford vaccine trial has been conducted in two ways. In one trial in England the first half dose was given and then a full dose a month later. Thus the vaccine was found to be 90 percent effective.

The second type of trial in Brazil gave two full doses of the vaccine a month. The effect of the vaccine was found to be 62 percent in this trial. Both types of results averaged 70 percent. 70% effective medicine is also considered good in medical science.

Corona Vaccine Price

Corona patients will need to be given two doses of the vaccine. These two doses of Pfizer Vaccine cost up to Rs. 3000. While two doses of Moderna Vaccine will cost Rs 5,550. Oxford and AstraZeneca doses will cost between Rs 1,000 and Rs 1,200.

Vaccine Storage temperature

The Pfizer company will require a temperature of -70 degrees for storage of the vaccine. A temperature of -20 degrees will be required to protect the mardana vaccine. While the Oxford and AstraZeneca vaccines can be kept at a temperature of 2 to 8 degrees. The low cost and ability to store at high temperatures make Oxford and AstraZeneca vaccines different from other companies.

Covishield in India

In India, the Oxford and AstraZeneca vaccines are being developed by the Serum Institute of India under the name Covishield. The trial of Kovishield is also in the final stage in India. The results of this trial will come in January next year.

100 Million Doses Ready by January

According to the policy commission, if AstraZeneca is approved in England, Covishield could be approved before the third phase of the trial in India. According to the commission, if DCGI approves the vaccine, 40 million doses of Covishield will be ready in India by early January. However, the company claims to have a stock of 100 million doses by January 2021 and then 5-6 million vaccines per month from January.

Click Here To Read In Gujarati 

Characteristics of the vaccine

The vaccine for Oxford and AstraZeneca is called AZD1222.

The vaccine can be stored at a temperature of 2 to 8 degrees.

It can be stored in the home freezer for up to 6 months.

Effective up to 70 percent in third phase trials.

No side effects were observed during the trial.

The cost of two doses of vaccine is Rs.1000-1200.

The vaccine in India is called Covishield.